The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
CCL
Vol.
32
No.
12
December 25, 2009
- ASCO Annual Report Names Significant Clinical Research Advances Of Past Year
- Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial
- Tykerb Plus Herceptin Better Than Monotherapy, Study Says
- Bisphosphonates May Reduce Recurrent Breast Cancer
- Study Finds High-Risk Women Reluctant To Take Tamoxifen
- Cervical Cancer Screening Can Be Done Later, Less Often
- No Benefit For Cetuximab In Early-Stage Colon Cancer
- NCI Cooperative Group Clinical Trials Approved
